Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.

The Journal of Biological Chemistry
S YamagishiZenji Makita

Abstract

Advanced glycation end products (AGE) have been implicated in the pathogenesis of glomerulosclerosis in diabetes. However, their involvement in the development of the early phase of diabetic nephropathy has not been fully elucidated. We investigated the effects of AGE on growth and on vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (MCP-1) expression in human cultured mesangial cells. We prepared three immunochemically distinct AGE by incubating bovine serum albumin (BSA) with glucose, glyceraldehyde, or glycolaldehyde. When human mesangial cells were cultured with various types of AGE-BSA, viable cell numbers as well as DNA syntheses were significantly decreased. All of the AGE-BSA were found to significantly increase p53 and Bax protein accumulations and subsequently induce apoptotic cell death in mesangial cells. An antioxidant, N-acetylcysteine, significantly prevented the AGE-induced apoptotic cell death in mesangial cells. Human mesangial cells stimulated prostacyclin production by co-cultured glomerular endothelial cells. Furthermore, various types of AGE-BSA were found to up-regulate the levels of mRNAs for VEGF and stimulate the secretion of VEGF and MCP-1 proteins in mesangial cells. T...Continue Reading

References

Mar 1, 1978·Diabetes·M M Bern
Sep 19, 1991·The New England Journal of Medicine·Z MakitaH Vlassara
Feb 21, 1991·The American Journal of Medicine·A S KrolewskiA R Christlieb
May 19, 1988·The New England Journal of Medicine·M BrownleeH Vlassara
Oct 1, 1987·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D Schlondorff
Jan 1, 1988·Mayo Clinic Proceedings·J V DonadioJ C Romero
Jan 1, 1981·Annual Review of Biochemistry·M Brownlee, A Cerami
Dec 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·U O Wenzel, H E Abboud
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·R BucalaH Vlassara
Apr 1, 1993·Endocrine Reviews·R A Schwartzman, J A Cidlowski
Mar 1, 1993·Molecular and Cellular Biology·E Yonish-RouachM Oren
Mar 31, 1993·Biochemical and Biophysical Research Communications·S YamagishiH Yamamoto
Feb 7, 1998·The Journal of Biological Chemistry·M L AgarwalG R Stark
Sep 12, 1998·Science·J M Adams, S Cory
May 18, 1999·Biochemical and Biophysical Research Communications·S YamagishiH Yamamoto
Feb 29, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D S RajM Levi
Jan 4, 2001·Journal of Neuropathology and Experimental Neurology·M TakeuchiZ Makita
Apr 24, 2001·Journal of the American Society of Nephrology : JASN·An S DE VrieseNorbert H Lameire
Jul 18, 2001·The Journal of Clinical Investigation·Y YamamotoH Yamamoto
Jan 19, 2002·Biochemical and Biophysical Research Communications·Sho-ichi YamagishiZenji Makita
Feb 20, 2002·FEBS Letters·Tathagata ChoudhuriGaurisankar Sa

❮ Previous
Next ❯

Citations

Dec 17, 2008·European Journal of Nutrition·Takashi SatoMasayoshi Takeuchi
Jun 26, 2013·Journal of Natural Medicines·You-Hua XuQuan Zhu
Mar 17, 2004·Current Atherosclerosis Reports·Mehdi H Shishehbor, Deepak L Bhatt
Nov 8, 2008·Current Diabetes Reports·Yan Chun Li
Feb 19, 2008·Archives of Pharmacal Research·Chang Joo OhJeen-Woo Park
Mar 31, 2005·Biochemical and Biophysical Research Communications·Hideaki MiyajimaNorimasa Sawada
Jun 24, 2006·Biochemical and Biophysical Research Communications·Parameswaran G SreekumarDavid R Hinton
Sep 25, 2002·Life Sciences·Yosuke InagakiZenji Makita
Jul 1, 2009·Expert Reviews in Molecular Medicine·Puneet KumarSarah Y Yuan
Mar 12, 2009·Accounts of Chemical Research·Jennifer B TreweekKim D Janda
Apr 8, 2011·The Journal of Biological Chemistry·Tatsuya TominagaToshio Doi
Nov 3, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Leyi GuYasuhiko Tomino
Dec 22, 2004·Kidney International·Rangnath MishraMichael S Simonson
Jul 16, 2010·Journal of Oncology·Jun-Ichi TakinoMasayoshi Takeuchi
Aug 26, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Eva RiedlHannes Koeppel
Feb 26, 2004·Bioscience, Biotechnology, and Biochemistry·Teruyuki UsuiFumitaka Hayase
Sep 11, 2007·Bioscience, Biotechnology, and Biochemistry·Teruyuki UsuiFumitaka Hayase
Jul 18, 2009·Journal of the American Society of Nephrology : JASN·Ambra PozziPaul Voziyan
Aug 4, 2004·Proceedings of the National Academy of Sciences of the United States of America·Changyong LuHelen Vlassara
Apr 20, 2014·Ageing Research Reviews·F RocaE Boulanger
Nov 27, 2004·Diabetes Research and Clinical Practice·Naotaka SekiguchiHajime Nawata
Nov 4, 2004·Biochemical and Biophysical Research Communications·Ai Hyang ShinJeen-Woo Park
Aug 6, 2014·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Abhishek MaanE Kevin Heist
Sep 10, 2014·Chemico-biological Interactions·P MuthennaG Bhanuprakash Reddy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis